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Primary benign tumors of the trachea are uncommon. These tumors may cause tracheal occlusion and
lead to a misdiagnosis of asthma. Ectopic parathyroid adenoma (EPA) can be seen anywhere between the
mandibular angle and the mediastinum. The distal part of the trachea is a rare location for EPA, and EPA
obstructing the endotracheal lumen has not been reported in the literature. We herein describe a 52-
year-old female with a several-year history of asthma treatment who presented with progressive dys-
pnea. Computed tomography revealed a mass that was obstructing the tracheal lumen. Total mass
excision was performed via endobronchial treatment, and pathologic examination revealed EPA.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).Introduction
Primary benign tumors of the trachea and main bronchi are
uncommon. Such tumors often grow undetected and obstruct a
major portion of the tracheobronchial lumen before symptoms
such as dyspnea, wheezing, and stridor develops. They are often
misdiagnosed as asthma and can remain undetected for months or
years [1]. The parathyroid (PT) glands generally lie close to the
posterior surface of the thyroid lobes, and there are usually four PT
glands in humans [2]. Ectopic PT glands can be seen from the front
of the bifurcation of the carotid artery to the pericardium because
of the long path of migration of the thymus during the embryo-
logical period [3]. In this case report, we present a case involving an
ectopic PT adenoma (EPA) obstructing the tracheal lumen and
located in the distal part of the trachea. To date, such a case has
never been reported in the literature.Case report
A 52-year-old female patient with a 5-year history of asthma
treatment was hospitalized after being referred to our center with a, Inta A blk, D.18 G€oztepe,
52227 (home); fax: þ90 212
an).
Ltd. This is an open access article uprediagnosis of a tracheal mass. Thoracic computed tomography
(CT) had been performed because of progressive dyspnea; the mass
was found to be almost completely obstructing the distal part of the
trachea. The patient was a nonsmoker and had no signiﬁcant
medical history with the exception of two myomectomies.
In the pulmonary oscultation, the expiration was found to be
long and there were widespread bilaterally rhonchi. There were no
pathological ﬁnding in other systems' examinations. Biochemical
blood analysis and complete blood counts were normal. Patient's
epicentral thorax CT showed a polypoid lesion with sizes of
22  19 mm in the trachea with a posterior soft tissue extension
(Fig. 1).
Flexible bronchoscopy was performed with a prediagnosis of a
tracheal mass. A vegetating polypoid lesion that was constricting
90% of the distal part of the tracheal lumen was identiﬁed (Fig. 2).
The procedure was terminated by planning endobronchial treat-
ment with rigid bronchoscopy under general anesthesia because of
the inability to progress further to the distal part of the lesion, the
need for airway security, and the lesion's tendency to hemorrhage.
Rigid bronchoscopy revealed a pink mass with hypervascular
nodular formation on its surface obliterating 95% of the distal
tracheal lumen. The mass was treated by argon plasma coagulation
(APC) and neodymium: yttriumealuminum garnet (Nd:YAG) laser
photoresection (Video 1). Debris was removed by a biopsy forceps
and aspiration catheter. The tracheal lumen was fully opened
(Fig. 3). The biopsy report identiﬁed the lesion as an abnormally
located PT adenoma (Fig. 4). After this report of EPA, blood analysisnder the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
Fig. 1. Pulmonary CT scan images reformated in oblic axial (a) and coronal (b) planes showed a polypoid lesion with sizes of 22  19 mm in the trachea with a posterio rsoft tissue
extension.
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(PTH): 48.3 pg/mL (normal range: 15e65 pg/mL), Calcium (Ca):
9.95 (normal range: 8e10.6 mg/dl), and Calcium in 24 h urine:
253 mg/day (100e300 mg/day) were found. According to these
results, EPA was determined as nonfunctional.
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.rmcr.2014.07.006.
PT scintigraphy was performed with technetium 99m methox-
yisobutylisonitrile (Tc-99m MIBI). On the early image at 15 min, a
focal area of increased uptake of Tc-99m MIBI was observed in the
right posterolateral wall of the trachea. The focal uptake continued
on the delayed images acquired after the second hour of injection.
No evidence of adenomas in other ﬁelds was found (Fig. 5). Single-
photon emission CT (SPECT) was performed to determine the exact
location of the lesion. The lesion was located in the right postero-
lateral wall of the trachea (Fig. 5). Surgery was performed to
remove the remaining tissue. Positron emission tomography/CT
with 18F-ﬂuorodeoxyglucose (18F-FDG PET/CT) was performed
preoperatively to determine themetabolic activity of the suspicious
lesion located in the trachea and to identify possible metastasis.
The lesionwas located in the right posterolateral wall of trachea; its
maximum standardized uptake value (SUVmax) was 10.6, and itFig. 2. Fiberoptic bronchoscopy revealed a vegetating polypoid lesion which was
constricting 80% of the distal part of the tracheal lumen.measured 17 1219mm. Therewere no other abnormal ﬁndings
on PET/CT (Fig. 5).
Right posterolateral thoracotomy was performed, and the right
hemithoraxwas explored. A 2-cm tumorwas found in the distal part
of the trachea, extending from the membranous surface to the
posterior mediastinum, starting 2 cm above the carina and
extending 2 cm cranially. The trachea was dissected from the sur-
rounding tissues at this site. After dissection, the trachea was
circularly incised 1 cmproximally and 1 cmdistally; a total of 4 cmof
tracheal tissue was resected. No postoperative complications
occurred. The patient was discharged on the ﬁfth postoperative day.
Histopathological examination showed that the mass contained
pathological PT tissue. The tissue was not immunoreactive to
pancytokeratin, chromogranin, or CD 56 antibodies. The Ki-67
proliferation index was 2%. In light of these ﬁndings, the mass
was determined to be adenomatous ectopic PT tissue (Fig. 6).
Discussion
EPAs are rare and usually associated with the structures devel-
oping from the third and fourth pharyngeal clefts. They can be seen
in various locations due to the differences in embryological
development [4]. The most commonly seen ectopic location is theFig. 3. View of tracheal lumen after the removal of the mass with rigid bronchoscopy.
Fig. 4. Parathyroid tissue in the mass which was removed endobronchially, showing a
combination of Chief and oxyphil cells (H&E stain 400X).
Fig. 6. Parathyroid tissue showing a combination of Chief and oxyphil cells after
resection (H&E stain 40  10).
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include the inner aspect of the thyroid, neighboring region of the
para-aortic arch, anterior aspect of the sternocleidomastoideus
muscle, neighboring region of the hypoglossal nerve, para-
esophageal region, anterior mediastinum, aortopulmonary win-
dow, and pericardium [5]. In our case, the EPA was locatedFig. 5. On the early images at 15 min (G) a focal increased uptake of 99mTc-MIBI was observe
hour of injection (H). SPECT/CT was performed in order to determine the exact localization o
CT (D: SPECT images, E: CT images, F: SPECT/CT fused images).posterolateral to the trachea and passed through the intratracheal
area, resulting in an almost complete constriction. To the best of our
knowledge, an ectopic localization consistent with that in the
present case has not been reported in the literature to date.
A bronchial asthma-like syndrome may also be seen in patients
with upper airway obstructions of both extrathoracic (e.g., vocald at mediastinum. Focal uptake continued at delayed images acquired after the second
f the lesion. Lesion was located in the right posterolateral wall of trachea similar as PET/
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(e.g., tracheal stenosis, endobronchial tumors). Benign endobron-
chial tumors are characterized by a slow growth rate and generally
present with a dry cough and wheezing. Intermittent, low-grade
respiratory symptoms can often be misdiagnosed as asthma [6].
Thus, diagnosis of conditions other than bronchial asthma should
be considered when the initial evaluation suggests their presence
or when the patient does not respond to conventional asthma
medications [7]. Our patient was being followed with an asthma
diagnosis for several years. Because of her dyspnea and asthma
diagnosis secondary to constriction of the tracheal lumen by
ectopic PT tissue, the patient had a treatment history of inhaled
steroids and betamimetic agents.
Various localization and screening techniques for PT adenoma
are used for misdiagnosed or missed PT adenomas. These tech-
niques are performed routinely because of the development of
nuclear techniques that are less invasive. Ultrasound, Tc-99m MIBI
scintigraphy, SPECT, and MRI are the most commonly used nonin-
vasive methods [8]. Tc-99m MIBI PT scintigraphy is used widely for
the localization of PT pathologies, and the sensitivity and speciﬁcity
of diagnosis of PT adenomas are 91.0% and 98.8%, respectively [9].
The Tc-99m sestamibi remains in the PT gland but is immediately
cleared from the thyroid gland, allowing for localization of the PT
glands in the neck. If SPECT is added to Tc-99m MIBI scintigraphy,
the probability of ﬁnding a PT adenoma increases. The positive
predictive value of this technique was 95% in one study [10]. In our
patient, who had a prediagnosis of a tracheal mass, the mass was
urgently removed by rigid bronchoscopy for both diagnosis and
treatment. After a pathological diagnosis of EPA, Tc-99m MIBI
scintigraphy and SPECT/CT were performed. MIBI uptake was seen
in the right posterolateral distal part of the trachea, and this tissue
was considered to be an EPA. No evidence of an adenomawas found
in other sites.
Studies on the localization of PT adenoma with PET/CT have
been performed [11]. The role of PET/CT with 18F-FDG in cancer is
well documented in the literature. Evangelista et al. stated that PET/
CT is a highly sensitive tool in all phases of PT cancer [12]. With PET/
CT, both correct localization of the PT adenoma and determination
of the presence of multiglandular disease are possible [13]. In our
case, preoperative 18F-FDG PET/CT was performed to identify any
malignancy. A 1.6-  1.8-cm lesion in the right posterolateral distal
trachea, constricting lumen and demonstrating soft tissue density
(SUVmax, 6.9) was found. This lesion was present at the same site
shown with SPECT and MIBI scintigraphy.
Endobronchial bronchoscopic resection can be both diagnostic
and curative because of the benign nature of tracheal tumors. Many
endobronchial methods using rigid or ﬂexible bronchoscopy have
been developed for the treatment of these tumors. Nd: YAG laser
photoresection, cryotherapy, electrocautery, and APC are used to
provide airway openness [14,15]. In our case, because of the near-
complete obstruction by the tracheal mass, we primarily used
Nd: YAG laser photoresection followed by APC to clear the tumor
and provide airway openness.
The most appropriate surgical technique is dependent upon the
location of the adenoma. Thoracotomy is the preferred surgical
approach for lesions located in the middle and posterior medias-
tinum [16]. In our case, thoracotomy was performed to excise the
remaining residual tissue after rigid bronchoscopic PT adenoma
resection. Right posterolateral thoracotomy allowed the right
hemithorax to be explored. A 2-cm tumor was found in the distalpart of the trachea, extending from the membranous surface to the
posterior mediastinum, starting 2 cm above the carina and
extending 2 cm cranially. The trachea was dissected from the sur-
rounding tissues at this site. After dissection, the trachea was
incised circularly 1 cm proximally and 1 cm distally; a total of 4 cm
of tracheal tissue was resected.
In conclusion, PA may be seen endotracheally in an ectopic
location. Clinicians should be aware of this rare entity, which can
clinically mimic other common pulmonary pathologies, such as
bronchial asthma.
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